Ca
ABCA1
ABCG1
Atherosclerosis
Ca(v)3.1 T-type calcium channel
Cholesterol efflux
Macrophage
Journal
Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032
Informations de publication
Date de publication:
27 Feb 2024
27 Feb 2024
Historique:
received:
27
09
2023
revised:
29
01
2024
accepted:
26
02
2024
medline:
1
3
2024
pubmed:
1
3
2024
entrez:
29
2
2024
Statut:
aheadofprint
Résumé
Calcium channel blockers (CCBs) are commonly used as antihypertensive agents. While certain L-type CCBs exhibit antiatherogenic effects, the impact of Ca
Identifiants
pubmed: 38423188
pii: S0006-2952(24)00079-0
doi: 10.1016/j.bcp.2024.116096
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
116096Informations de copyright
Copyright © 2024. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.